CLLS - Cellectis - ADR
IEX Last Trade
2.41
0.010 0.415%
Share volume: 15,029
Last Updated: Fri 30 Aug 2024 06:16:48 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.40
0.01
0.42%
Summary score
8%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.53%
Return on assets
-6.2%
Return on sales
-1107%
Return on invested capital
-18.42%
Total debt ratio
22.65%
Debt ratio change over timeo
-0.67%
Current Ratio
7.76%
Quick Ratio
7.74%
Cash Position Ratio
6.43%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-5.26%
Return on assets
-4.82%
Return on sales
-605.59%
Return on invested capital
-91.68%
Total debt ratio
31.55%
Debt ratio change over timeo
-0.96%
Current Ratio
7.13%
Quick Ratio
7.06%
Cash Position Ratio
6.11%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-10.57%
Return on assets
-7.43%
Return on sales
-1202.03%
Return on invested capital
-45.35%
Total debt ratio
34.93%
Debt ratio change over time
-0.23%
Current Ratio
6.56%
Quick Ratio
6.45%
Cash Position Ratio
5.32%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-111.12%
Return on assets
-110.66%
Return on sales
-1973.61%
Return on invested capital
-20.06%
Total debt ratio
-66.79%
Debt ratio change over time
-0.67%
Current Ratio
11.86%
Quick Ratio
11.84%
Cash Position Ratio
9.1%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CLLS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -6.53% | -3.05% | 11.55% | 6.27% |
| Return on assets | -6.2% | 3.6% | 3.57% | 5.27% |
| Return on sales | -1107% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -18.42% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 22.65% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.67% | 6.09% | 6.03% | 1.53% |
| Dept financing | 6% | 50% | 43% | 14% |
| Current Ratio | 7.13% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 7.06% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 6.11% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 12% | 25% | 27% |
| Short-term ratios | CLLS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.26% | -25.62% | 17.94% | 7.14% |
| Return on assets | -4.82% | 3.26% | 3.67% | 4.71% |
| Return on sales | -605.59% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -91.68% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 31.55% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.96% | -23.44% | 9.66% | 0.6% |
| Dept financing | 7% | 25% | 45% | 8% |
| Current Ratio | 7.13% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 7.06% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 6.11% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 20% | 16% | 29% |